Literature DB >> 9932423

Molecular studies of prion diseases.

J Safar1, S B Prusiner.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9932423     DOI: 10.1016/s0079-6123(08)64030-3

Source DB:  PubMed          Journal:  Prog Brain Res        ISSN: 0079-6123            Impact factor:   2.453


× No keyword cloud information.
  10 in total

1.  Rapidly progressive Alzheimer's disease features distinct structures of amyloid-β.

Authors:  Mark L Cohen; Chae Kim; Tracy Haldiman; Mohamed ElHag; Prachi Mehndiratta; Termsarasab Pichet; Frances Lissemore; Michelle Shea; Yvonne Cohen; Wei Chen; Janis Blevins; Brian S Appleby; Krystyna Surewicz; Witold K Surewicz; Martha Sajatovic; Curtis Tatsuoka; Shulin Zhang; Ping Mayo; Mariusz Butkiewicz; Jonathan L Haines; Alan J Lerner; Jiri G Safar
Journal:  Brain       Date:  2015-02-15       Impact factor: 13.501

2.  Distinct populations of highly potent TAU seed conformers in rapidly progressing Alzheimer's disease.

Authors:  Chae Kim; Tracy Haldiman; Sang-Gyun Kang; Lenka Hromadkova; Zhuang Zhuang Han; Wei Chen; Frances Lissemore; Alan Lerner; Rohan de Silva; Mark L Cohen; David Westaway; Jiri G Safar
Journal:  Sci Transl Med       Date:  2022-01-05       Impact factor: 19.319

3.  Co-existence of distinct prion types enables conformational evolution of human PrPSc by competitive selection.

Authors:  Tracy Haldiman; Chae Kim; Yvonne Cohen; Wei Chen; Janis Blevins; Liuting Qing; Mark L Cohen; Jan Langeveld; Glenn C Telling; Qingzhong Kong; Jiri G Safar
Journal:  J Biol Chem       Date:  2013-08-23       Impact factor: 5.157

4.  Green fluorescent protein as a reporter of prion protein folding.

Authors:  Snezana Vasiljevic; Junyuan Ren; YongXiu Yao; Kevin Dalton; Catherine S Adamson; Ian M Jones
Journal:  Virol J       Date:  2006-08-29       Impact factor: 4.099

5.  The Features of Genetic Prion Diseases Based on Chinese Surveillance Program.

Authors:  Qi Shi; Wei Zhou; Cao Chen; Bao-Yun Zhang; Kang Xiao; Xiu-Chun Zhang; Xiao-Jing Shen; Qing Li; Li-Quan Deng; Jian-Hua Dong; Wen-Qing Lin; Pu Huang; Wei-Jia Jiang; Jie Lv; Jun Han; Xiao-Ping Dong
Journal:  PLoS One       Date:  2015-10-21       Impact factor: 3.240

6.  Co-occurrence of chronic traumatic encephalopathy and prion disease.

Authors:  Satish Kumar Nemani; Silvio Notari; Ignazio Cali; Victor E Alvarez; Diane Kofskey; Mark Cohen; Robert A Stern; Brian Appleby; Joseph Abrams; Lawrence Schonberger; Ann McKee; Pierluigi Gambetti
Journal:  Acta Neuropathol Commun       Date:  2018-12-18       Impact factor: 7.801

Review 7.  Implications of prion adaptation and evolution paradigm for human neurodegenerative diseases.

Authors:  M Enamul Kabir; Jiri G Safar
Journal:  Prion       Date:  2014 Jan-Feb       Impact factor: 3.931

8.  Structurally distinct external solvent-exposed domains drive replication of major human prions.

Authors:  Mohammad Khursheed Siddiqi; Chae Kim; Tracy Haldiman; Miroslava Kacirova; Benlian Wang; Jen Bohon; Mark R Chance; Janna Kiselar; Jiri G Safar
Journal:  PLoS Pathog       Date:  2021-06-17       Impact factor: 6.823

9.  Myositis facilitates preclinical accumulation of pathological prion protein in muscle.

Authors:  Melanie Neumann; Susanne Krasemann; Katharina Schröck; Karin Steinbach; Markus Glatzel
Journal:  Acta Neuropathol Commun       Date:  2013-12-03       Impact factor: 7.801

Review 10.  Emerging Role of Cellular Prion Protein in the Maintenance and Expansion of Glioma Stem Cells.

Authors:  Stefano Thellung; Alessandro Corsaro; Alessia G Bosio; Martina Zambito; Federica Barbieri; Michele Mazzanti; Tullio Florio
Journal:  Cells       Date:  2019-11-18       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.